The Frontier™ Platform
Proprietary platform powered by chemoproteomics, covalent chemistry, and machine learning
Patients
Enabling breakthrough medicines for patients by unlocking the proteome to small-molecule interventions against otherwise undruggable disease-causing targets
Pioneering
Harnessing a powerful platform by integrating cutting edge technologies such as machine learning, context-dependent screening, and rigorous biophysical and analytical methods
Precision
Developing precision medicines focused on genetically-defined patient populations to deliver the maximal benefit
